A DNA-PK phosphorylation site on MET regulates its signaling interface with the DNA damage response

Jonas P Koch1,2,3, Selina M Roth1,2,3, Aurélie Quintin1,2

  • 1Department for BioMedical Research, Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland.

Oncogene
|May 15, 2023
PubMed

Insights

Researchers discovered a new MET receptor tyrosine kinase (RTK) phosphosite, Serine 1016 (S1016), crucial for the DNA damage response (DDR). This finding offers insights into targeted therapies for radiosensitization and maintaining genome stability.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The DNA damage response (DDR) is closely linked to signaling pathways activated by oncogenic receptor tyrosine kinases (RTKs).
  • Understanding the molecular crosstalk between DDR and RTKs is essential for developing targeted therapies, particularly as radiosensitizers.

Purpose of the Study:

  • To characterize a novel MET RTK phosphosite, Serine 1016 (S1016), as a potential interface between the DDR and MET signaling.
  • To investigate the role of MET S1016 phosphorylation in cellular response to DNA damage and its implications for genome stability.

Main Methods:

  • Phosphoproteomic analysis to identify and characterize the MET S1016 phosphosite.
  • Irradiation experiments to assess changes in MET S1016 phosphorylation.
  • Site-directed mutagenesis (S1016A substitution) to study the functional impact of this phosphosite.
  • Cell cycle analysis and assessment of mitotic spindle formation.

Main Results:

  • A previously unreported MET RTK phosphosite, S1016, was identified and shown to be phosphorylated upon irradiation, primarily by DNA-dependent protein kinase (DNA-PK).
  • Abrogation of MET S1016 phosphorylation significantly impacts long-term cell cycle regulation following DNA damage, affecting proteins involved in cell cycle progression and mitotic spindle formation.
  • Cells lacking functional MET S1016 bypass G2 arrest upon irradiation, enter mitosis with compromised genome integrity, exhibit abnormal mitotic spindles, and show reduced proliferation.

Conclusions:

  • The study uncovers a novel signaling mechanism where the DDR utilizes the MET growth factor receptor system to regulate and maintain genome stability.
  • MET S1016 serves as a critical regulatory point connecting DNA damage signaling with cell cycle control and mitotic progression.
  • Targeting the MET S1016 phosphosite could represent a potential strategy for enhancing radiosensitization and improving cancer therapy outcomes.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.9K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.0K